Biomarkers for immunotherapy for treatment of glioblastoma

Immunotherapy is a promising new therapeutic field that has demonstrated significant benefits in many solid-tumor malignancies, such as metastatic melanoma and non-small cell lung cancer. However, only a subset of these patients responds to treatment. Glioblastoma (GBM) is the most common malignant...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Immunother Cancer
Main Authors: Lynes, John P, Nwankwo, Anthony K, Sur, Hannah P, Sanchez, Victoria E, Sarpong, Kwadwo A, Ariyo, Oluwatobi I, Dominah, Gifty A, Nduom, Edjah K
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2020
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7264836/
https://ncbi.nlm.nih.gov/pubmed/32474411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000348
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki